Developer docs
API playgroundTry for free, no card

Search company profiles

CryoCord

Full company profile

uuid0008v9m

Namestring
CryoCord
Websiteurl
cryocord.com.my
Company typeenum
Private
Founded yearint
2002
Descriptiontext

CryoCord is a Malaysia-based private stem cell bank founded in 2002 and headquartered in Selangor. The company offers stem cell banking services that leverage modern processing technology and secure storage facilities, serving consumers — typically expectant parents banking newborn cord blood and tissue for potential future medical use. As a for-profit, privately-held operator with a workforce in the 51–100 range, CryoCord sits in a niche consumer healthcare services category where revenue is generated through one-time enrollment fees combined with long-term storage contracts.

The business model is consistent with the broader cord blood banking industry: customers pay an upfront collection and processing fee followed by recurring annual storage fees, producing a recurring revenue tail that compounds as the installed customer base grows. CryoCord's headcount of 51–100 employees is consistent with mid-scale laboratory operations, cryogenic storage management, and a consumer-facing sales/marketing function targeting Malaysian families and, potentially, regional cross-border clients.

The company operates under a single identified leader — Managing Director James Then Khong Lek — and the public-facing website (cryocord.com.my) currently presents only a verification/loading interface rather than substantive marketing or technical content, which limits visibility into current pricing, facility footprint, partnerships, and product differentiation. No publicly disclosed funding rounds, acquisitions, partnerships, certifications, or regulatory actions were captured in the source data.

Short descriptiontext

CryoCord is a Malaysia-based private stem cell bank founded in 2002, headquartered in Selangor, that offers cord blood and tissue banking services to families using modern processing technology and secure long-term cryogenic storage facilities.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersCyberjaya, Malaysia
HQ citystring
Cyberjaya
HQ countrystring
Malaysia
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
stem cell banking, cord blood banking, cryogenic storage services, biological sample preservation, family cell banking
Industry2 codes
PRIMARYHLAAAGAE
Cell & Tissue Banking (biobanking, cord blood/tissue)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAGAGAK
Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
NAICS code1 code
  • Blood and Organ Banks621991
Product category
Stem Cell Banking
Social media profiles2 records
Cost components5 values
Personnel, Infrastructure, Operations, Technology or R&D, Marketing or Sales
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

CryoCord is a stem cell bank that provides stem cell collection, processing, and long-term cryogenic storage services to families. It utilizes modern technology supported by advanced and secure facilities to preserve biological samples for future medical use. The company is based in Selangor, Malaysia, and operates as a private for-profit family cord blood and stem cell bank.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

No product information available in the source data. The source page displays only a loading/verification message and does not contain any substantive content about CryoCord's products, services, or company offerings.

Product and service1 record
1Stem cell banking service
CategoryStem cell banking services
Description

End-to-end family stem cell banking: collection, processing and long-term cryogenic storage of cord blood and related biological samples for individual (family) customers in Malaysia, intended to preserve stem cells for potential future medical use.

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Peers10 records
1China Cord Blood Corporation
TypeRegional player
Description

Largest cord blood banking operator in China, with licences in multiple provinces. Comparable in core cord blood storage service but operates in a distinct regulatory and demographic geography from CryoCord.

2Global Cord Blood Corporation
TypeBroad incumbent
Description

Operator of multiple cord blood banks in Asia (including collaborations in China and Southeast Asia). Comparable as a multi-market, established cord blood banking platform with broader geographic reach than CryoCord.

TypeDirect peer
Description

UK-based cord blood stem cell bank, one of the longest-established private family banking services in Europe. Comparable in core proposition and customer demographic, and a useful benchmark for operational longevity in the niche.

TypeDirect peer
Description

Germany-listed stem cell bank offering umbilical cord blood and tissue storage plus related diagnostics. Directly comparable in business model — family banking with recurring annual storage fees and similar regulatory/compliance overhead.

5Cellsafe International
TypeDirect peer
Description

Malaysia-based stem cell bank offering cord blood and tissue storage services directly to Malaysian expectant parents. The closest head-to-head domestic competitor to CryoCord, sharing market, regulation, and customer base.

TypeDirect peer
Description

Global cord blood bank with both family-banking and public-banking operations. Directly comparable in core service (umbilical cord blood/tissue cryopreservation) and in serving both consumer and clinical/therapeutic end markets.

TypeDirect peer
Description

UK-headquartered stem cell bank offering cord blood, cord tissue, and peripheral blood stem cell storage. Directly comparable to CryoCord in core storage proposition and in selling long-duration cryopreservation services to families.

TypeDirect peer
Description

Stem cell bank operating across South and Southeast Asia offering cord blood and cord tissue storage. Highly comparable to CryoCord in service mix, target customer (expectant parents), and regional footprint.

TypeDirect peer
Description

Singapore-headquartered, regionally listed stem cell bank with operations across Southeast Asia including Malaysia. Directly comparable to CryoCord as a cord blood/tissue banking service provider targeting parents in the same ASEAN geography.

TypeDirect peer
Description

UK-based cord blood and tissue bank operating multiple processing/storage sites. Comparable in service portfolio (whole cord blood, cord tissue, cell type splits) and in targeting expectant parents with premium storage offerings.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CryoCord

Stem Cell Bankingcryocord.com.my

CryoCord is a Malaysia-based private stem cell bank founded in 2002, headquartered in Selangor, that offers cord blood and tissue banking services to families using modern processing technology and secure long-term cryogenic storage facilities.

What CryoCord does

CryoCord is a Malaysia-based private stem cell bank founded in 2002 and headquartered in Selangor. The company offers stem cell banking services that leverage modern processing technology and secure storage facilities, serving consumers — typically expectant parents banking newborn cord blood and tissue for potential future medical use. As a for-profit, privately-held operator with a workforce in the 51–100 range, CryoCord sits in a niche consumer healthcare services category where revenue is generated through one-time enrollment fees combined with long-term storage contracts.

The business model is consistent with the broader cord blood banking industry: customers pay an upfront collection and processing fee followed by recurring annual storage fees, producing a recurring revenue tail that compounds as the installed customer base grows. CryoCord's headcount of 51–100 employees is consistent with mid-scale laboratory operations, cryogenic storage management, and a consumer-facing sales/marketing function targeting Malaysian families and, potentially, regional cross-border clients.

The company operates under a single identified leader — Managing Director James Then Khong Lek — and the public-facing website (cryocord.com.my) currently presents only a verification/loading interface rather than substantive marketing or technical content, which limits visibility into current pricing, facility footprint, partnerships, and product differentiation. No publicly disclosed funding rounds, acquisitions, partnerships, certifications, or regulatory actions were captured in the source data.

CryoCord firmographics

Firmographics
Name
CryoCord
Website
https://cryocord.com.my
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
101–250 employees
Short description
CryoCord is a Malaysia-based private stem cell bank founded in 2002, headquartered in Selangor, that offers cord blood and tissue banking services to families using modern processing technology and secure long-term cryogenic storage facilities.
Ownership category
akta.pro rank

CryoCord industry classification

Industry
Product category
Stem Cell Banking
NAICS
Blood and Organ Banks (621991)
akta.pro industry
PRIMARYHLAAAGAE
Cell & Tissue Banking (biobanking, cord blood/tissue)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAGAGAK
Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)

Keywords

  • Stem cell banking
  • Cord blood banking
  • Cryogenic storage services
  • Biological sample preservation
  • Family cell banking

Where CryoCord is headquartered

Location

Headquarters

HQ city
Cyberjaya
HQ country
Malaysia
HQ region
Asia

Markets served

CryoCord business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Infrastructure, Operations, Technology or R&D, Marketing or Sales

CryoCord product offering

Product offering

Core offering

CryoCord is a stem cell bank that provides stem cell collection, processing, and long-term cryogenic storage services to families. It utilizes modern technology supported by advanced and secure facilities to preserve biological samples for future medical use. The company is based in Selangor, Malaysia, and operates as a private for-profit family cord blood and stem cell bank.

Product overview

No product information available in the source data. The source page displays only a loading/verification message and does not contain any substantive content about CryoCord's products, services, or company offerings.

Differentiator

Problem solved

Functional benefit

Products and services

  • Stem cell banking service End-to-end family stem cell banking: collection, processing and long-term cryogenic storage of cord blood and related biological samples for individual (family) customers in Malaysia, intended to preserve stem cells for potential future medical use.

Companies that use CryoCord

Customer profile

Ideal customer profiles1 record

CryoCord technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

CryoCord partnerships and signals

Strategic signal

Recent moves1 record

CryoCord competitors and assessment

Company assessment

Regional players

  • China Cord Blood Corporation: Largest cord blood banking operator in China, with licences in multiple provinces. Comparable in core cord blood storage service but operates in a distinct regulatory and demographic geography from CryoCord.

Broad incumbents

  • Global Cord Blood Corporation: Operator of multiple cord blood banks in Asia (including collaborations in China and Southeast Asia). Comparable as a multi-market, established cord blood banking platform with broader geographic reach than CryoCord.

Direct peers

  • Smart Cells International: UK-based cord blood stem cell bank, one of the longest-established private family banking services in Europe. Comparable in core proposition and customer demographic, and a useful benchmark for operational longevity in the niche.
  • Vita 34: Germany-listed stem cell bank offering umbilical cord blood and tissue storage plus related diagnostics. Directly comparable in business model — family banking with recurring annual storage fees and similar regulatory/compliance overhead.
  • Cellsafe International: Malaysia-based stem cell bank offering cord blood and tissue storage services directly to Malaysian expectant parents. The closest head-to-head domestic competitor to CryoCord, sharing market, regulation, and customer base.
  • StemCyte: Global cord blood bank with both family-banking and public-banking operations. Directly comparable in core service (umbilical cord blood/tissue cryopreservation) and in serving both consumer and clinical/therapeutic end markets.
  • Future Health Biobank: UK-headquartered stem cell bank offering cord blood, cord tissue, and peripheral blood stem cell storage. Directly comparable to CryoCord in core storage proposition and in selling long-duration cryopreservation services to families.
  • Cryoviva: Stem cell bank operating across South and Southeast Asia offering cord blood and cord tissue storage. Highly comparable to CryoCord in service mix, target customer (expectant parents), and regional footprint.
  • Cordlife Group: Singapore-headquartered, regionally listed stem cell bank with operations across Southeast Asia including Malaysia. Directly comparable to CryoCord as a cord blood/tissue banking service provider targeting parents in the same ASEAN geography.
  • Cells4Life: UK-based cord blood and tissue bank operating multiple processing/storage sites. Comparable in service portfolio (whole cord blood, cord tissue, cell type splits) and in targeting expectant parents with premium storage offerings.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

CryoCord social profiles

Digital presence

CryoCord financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CryoCord leadership team

Management profile

Number of profiles

Profiles1 record

CryoCord funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CryoCord M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CryoCord

What does CryoCord do?

CryoCord is a stem cell bank that provides stem cell collection, processing, and long-term cryogenic storage services to families. It utilizes modern technology supported by advanced and secure facilities to preserve biological samples for future medical use. The company is based in Selangor, Malaysia, and operates as a private for-profit family cord blood and stem cell bank.

When was CryoCord founded?

CryoCord was founded in 2002. It employs 101 to 250 people.

Where is CryoCord based?

CryoCord is headquartered in Cyberjaya, Malaysia, in the Asia region.

Who are CryoCord's main competitors?

China Cord Blood Corporation is listed as a regional player. Global Cord Blood Corporation is listed as a broad incumbent. Direct peers are Smart Cells International, Vita 34, Cellsafe International, StemCyte, Future Health Biobank, Cryoviva, Cordlife Group and Cells4Life.

Does CryoCord have an API?

No public API is recorded for CryoCord.

What industry is CryoCord in?

CryoCord's product category is Stem Cell Banking. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue), with a secondary code of HLAGAGAK, Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low). Its NAICS code is 621991.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales